A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL

Recruiting now · Not applicable

Conditions studied: Diffuse Large B Cell Lymphoma, CAR-T, Radiotherapy, Bridging Therapy

In brief

This is a single-arm single center study to prospectively evaluate the safety and efficacy of ultra-fraction radiotherapy bridging CAR-T therapy in relapsed/refractory diffuse large b cell lymphoma

Key facts

Study ID
NCT05514327
Run by
Peking Union Medical College Hospital
People needed
20
Starts
2022-09-01
Expected to finish
2028-12-01
Last updated by the study team
2026-03-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.